Search - tctmd.com

Displaying 1 - 20 of 134

Sort: Relevancy | Date

News Opinion CV Team Dispatch

December 2022 News Roundup

L.A. McKeown

December 28, 2022

News Daily News

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

Michael O'Riordan

December 22, 2022

News Daily News

Rare and Highly Variable, Cath Lab Cardiac Arrests Need More Study, Guidance

L.A. McKeown

December 20, 2022

News Daily News

Reduction in BP Drives Treatment Preference for Hypertensive Patients

Michael O'Riordan

December 20, 2022

News Daily News

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Caitlin E. Cox

December 09, 2022

News Daily News

Expert Consensus Advocates for Normalizing Pregnancy in Cath Labs

L.A. McKeown

December 08, 2022

News Daily News

Interventional Cardiology Fellowship to Move to a Match for 2025

Yael L. Maxwell

December 07, 2022

News Daily News

FDA: Endologix AAA Grafts Get New Labeling That Addresses Endoleak Potential

L.A. McKeown

December 06, 2022

News Features

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

L.A. McKeown

December 02, 2022

Earlier Interventions and Later Redos? ‘Mature’ TAVI Still Has Growing Pains

Shelley Wood

November 28, 2022

News Daily News

Less Occlusion, Hematomas With Distal Radial Access: Meta-analysis

Michael O'Riordan

November 22, 2022

News Conference News

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

L.A. McKeown

November 18, 2022

News Daily News

Many STEMI Patients Not Treated Within National Time Goals

Michael O'Riordan

November 15, 2022

News Conference News AHA 2022

Chinese Medicine Tongxinluo Yields ‘Surprising’ Benefits Post-STEMI: CTS-AMI

Shelley Wood

November 10, 2022

News Conference News AHA 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

Todd Neale

November 09, 2022

News Conference News AHA 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

L.A. McKeown

November 07, 2022

News Conference News AHA 2022

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

Michael O'Riordan

November 04, 2022

News Conference News VIVA 2022

‘Heartless’ Indifference Drives PAD/CLTI Amputations in Underserved Groups

L.A. McKeown

November 04, 2022

News Conference News VIVA 2022

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

L.A. McKeown

November 03, 2022

Advertisement

December 2022 News Roundup

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

Rare and Highly Variable, Cath Lab Cardiac Arrests Need More Study, Guidance

Reduction in BP Drives Treatment Preference for Hypertensive Patients

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Expert Consensus Advocates for Normalizing Pregnancy in Cath Labs

Interventional Cardiology Fellowship to Move to a Match for 2025

FDA: Endologix AAA Grafts Get New Labeling That Addresses Endoleak Potential

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

Earlier Interventions and Later Redos? ‘Mature’ TAVI Still Has Growing Pains

Less Occlusion, Hematomas With Distal Radial Access: Meta-analysis

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

Many STEMI Patients Not Treated Within National Time Goals

Chinese Medicine Tongxinluo Yields ‘Surprising’ Benefits Post-STEMI: CTS-AMI

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

‘Heartless’ Indifference Drives PAD/CLTI Amputations in Underserved Groups

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content